Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Poly-Vi-Flor and Tri-Vi-Flor are prescription-strength pediatric multivitamin supplements containing sodium fluoride, developed and marketed by Aytu BioPharma. These products are indicated for the prevention and treatment of fluoride deficiency and the prophylaxis of dental caries in infants and children, particularly those living in areas where drinking water is not sufficiently fluoridated. Poly-Vi-Flor typically contains a broader range of vitamins (A, C, D, E, and B-complex), while Tri-Vi-Flor contains vitamins A, C, and D. Both formulations include sodium fluoride, which works by strengthening dental enamel and increasing resistance to acid-driven tooth decay. They are available in various oral dosage forms, including liquid drops for infants and chewable tablets for older children.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Poly-Vi-Flor + Tri-Vi-Flor.